BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
7,8800
12-ноября-24 14:26:12
15 мин. задержка
Акции
-0,3100
-3,79%
Сегодняшний диапазон
7,8300 - 8,2400
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 июл 2023 07:00:12 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 июн 2023 07:00:42 Источник Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conference
01 июн 2023 07:00:45 Источник Nasdaq GlobeNewswire
-
31 май 2023 07:02:04 Источник Nasdaq GlobeNewswire
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Public Health Institute of Chile
22 май 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 май 2023 16:01:01 Источник Nasdaq GlobeNewswire
-
BioCryst Reports First Quarter 2023 Financial Results and Provides Business Update
03 май 2023 07:00:55 Источник Nasdaq GlobeNewswire
-
27 апр 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
BioCryst to Report First Quarter 2023 Financial Results on May 3
19 апр 2023 07:00:27 Источник Nasdaq GlobeNewswire
-
BioCryst Refinances Existing Debt with $450 Million Financing Commitment from Pharmakon
18 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
12 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 апр 2023 07:00:36 Источник Nasdaq GlobeNewswire
-
BioCryst Appoints Dr. Nancy Hutson as Chair of the Board
31 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst Celebrates Bob Ingram’s Contributions to the Company’s Success
29 мар 2023 16:01:31 Источник Nasdaq GlobeNewswire
-
08 мар 2023 15:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 мар 2023 07:00:13 Источник Nasdaq GlobeNewswire
-
24 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
22 фев 2023 07:00:04 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Key Milestones
21 фев 2023 07:00:23 Источник Nasdaq GlobeNewswire
-
BioCryst to Report Fourth Quarter 2022 Financial Results on February 21
07 фев 2023 07:00:16 Источник Nasdaq GlobeNewswire